A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
- Magnus Nakrem Lyngbakken
- Jan-Erik Berdal
- Arne Eskesen
- Dag Kvale
- Inge Christoffer Olsen
- Corina Silvia Rueegg
- Anbjørg Rangberg
- Christine Monceyron Jonassen
- Torbjørn Omland
- Helge Røsjø
- Olav Dalgard
Publication date
October 2020
DOI Publisher
Springer Science and Business Media LLC Journal
Nature CommunicationsAbstract
The use of hydroxychloroquine therapy for the treatment of Covid-19 is controversial. In this study, Lyngbakken and colleagues present a randomized controlled trial and show that the drug has no antiviral effects in humans infected with SARS-CoV-2
Add to ORKG